Looking for:
ventolin |
If you are interested in trying one of them, I would talk to your doctor to discuss what would be appropriate for you. Biotechs raised just $2.2 billion in new stock offerings this year, a decline of more than 80% from the roughly $14.7 billion drugmakers hauled in a year ago. "We currently don't anticipate a supply impact to Ventolin HFA 200D inhaler as a result of this issue," GSK added in a statement. “We currently don’t anticipate a supply impact to Ventolin HFA 200D inhaler as a result of this issue,” GSK said in a statement. Good Housekeeping participates in various affiliate marketing programs, which means we may get paid commissions on editorially chosen products purchased through our links to retailer sites.
When functioning properly, the metered-dose inhaler releases a fixed dose of medication in aerosol form. GSK says patients using the inhalers are not in danger, so they don't need to return the product. People with inhalers that match the expiration date on the Ventolin HFA inhaler, but not the lot number, are not impacted by the recall. The following month, the company expanded the recall, including additional batches of the Ventolin HFA inhaler, the Asthma and Allergy Foundation of America reported. Viral Facebook posts have rehashed an old recall, causing hundreds of thousands of people unnecessary concern.
A spokesperson for GlaxoSmithKline told Reuters at the time that the recall did not represent a risk to the public, and that the public were not required to return any affected inhalers. The voluntary recall targets Ventolin HFA Inhalation Aerosol, distributed via prescription nationwide. It is important to stay up-to-date on news about asthma and allergies. By joining our community and following our blog, you will be able to receive breaking news about research and treatments. Our community also provides an opportunity to connect with other patients who manage these conditions for peer support. The Asthma and Allergy Foundation of America is a non-profit organization and we are reporting this recall to inform people with asthma who rely on this medication.
The affected inhalers come from three manufacturing lots at a plant in Zebulon, North Carolina. The plant is currently still making the inhalers, but GSK says it has plans to identify the issue and take corrective action. The voluntary retail-level recall affects only two lots of Ventolin HFA. The recall does not extend beyond the US.
Ventolin inhalers are used to treat a number of conditions, but are primarily prescribed as a treatment for asthma. Reuters reports the company saw a spike in complaints from customers about bulging on the outside wrapper of the inhalers, which indicates the propellant that delivers the medicine is leaking. GlaxoSmithKline is now looking into what may have caused the problem. GlaxoSmithKline is recalling nearly 600,000 Ventolin asthma inhalers in the United States because of a defect that may cause them to leak.
GlaxoSmithKline is recalling more than 590,000 albuterol inhalers. Three lots of Ventolin HFA 200D inhalers have been voluntarily recalled due to a potential issues with the delivery system, a spokesman for the British pharmaceutical company said. An FDA document indicates the reason for the recall is a "defective delivery system" due to a leak in the Ventolin inhalers. Reuters reports drugmaker GSK is trying to figure out what caused the problem after an increasing number of complaints, and is pulling the inhalers from hospitals, pharmacies, retailers and wholesalers. The company said it had received an elevated number of product complaints about a bulging of the outside wrapper, indicating a leak of the propellant that delivers the medicine.
– More than 593,000 asthma inhalers in the United States have been recalled because of a problem that could cause them to deliver less medication than intended. No other lots are affected by the voluntary recall, meaning that, regardless of expiration date or doses indicated in dose counters, only inhalers in these two lots are affected. A GSK spokesman spoke with AAFA and said the recall is due to some complaints about the overwrap, or pouches containing the inhalers, becoming inflated by leaking from the product. The leaking may cause the inhaler to deliver fewer doses than shown on the dose counter. Glaxo's Ventolin inhalers have been available since 1969, and are used by many of the 25 million asthmatics in the U.S.
Three lots of Ventolin HFA 200D Inhalers are impacted; they have lot numbers of 6ZP9848, 6ZP0003 and 6ZP9944. Get browser notifications for breaking news, live events, and exclusive reporting. If you want to know these charges, please ask the administrator at our site and we would be happy to provide you with this information.
Comments
Post a Comment